Patent Yard Sign in
Expired Canadian patentCanada

Tetrahydrocarbazole 1-alkanoic acids

CA 1299577 C · Owner: Yoakim, Christiane · Inventors: Yoakim, Christiane; Gillard, John W.; Guindon, Yvan

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Tetrahydrocarbazole 1-alkanoic acids are disclosed. The compounds act as prostaglandin and thromboxane antagonists and are useful in treating asthma, diarrhea, hypertension, angina platelet, aggregation, cerebral spasm, premature labor spontaneous abortion and dysmenorrhea and as cytoprotective agents, and have the following general formula:, I, wherein:, R1, R2, R3, R4, R5 and R6 are each independently selected from:, (1) hydrogen; (2) alkyl having 1 to 6 carbon atoms;, (3) alkenyl having 2 to 6 carbon atoms; (4) -(CH2)nM, wherein n is O to 3 and M is a) OR13;, b) halogen;, c) CF3;, d) SR13; e) phenyl or substituted phenyl, wherein substituted phenyl i s as defined below in the, definition …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Granted April 28, 1992. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended April 28, 2009.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJanuary 9, 1987
GrantedApril 28, 1992
Term endedApril 28, 2009
Patent numberCA 1299577 C
Classification (IPC)C07D209/82 +2 more

Timeline

Timeline From CIPO dates

19881991199419972000200320062009Application filedJan 9, 1987Patent grantedApril 28, 1992Term endedApril 28, 2009

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.